Joukahaisenkatu 6, Turku, 20520, Finland
Clinical stage biopharmaceutical company developing novel treatments.
Total Raised
$39 M
Rounds
1
Links
Verticals
Equity
Aug 2024
$39M
Juho Jalkanen
CEO
James M. O’Brien
Chief Financial Officer
Greg Brown
Director
Petri Bono
CMO
